A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Cnalsium is a central nervous system (CNS) regulator with broad applicability in the treatment of neurodegenerative disorders. By acting on various neurotransmitter systems and promoting neural health, Cnalsium offers a novel approach to managing these challenging conditions.
»Optional Image« | |
Year Created: | YE 45 |
Designer / Manufacturer: | Advancer Enterprises |
Nomenclature: | AE-N37 |
Price: | 12 KS per 100mg tablet |
Cnalsium was developed in response to the growing prevalence of neurodegenerative disorders among Nepleslian Reds Gen2 clones missing their health checks, which have long posed a challenge to healthcare systems. Advancer Enterprises saw an opportunity to innovate in this space, investing in extensive research and development. The result was Cnalsium, a medication that not only alleviates symptoms but also slows the progression of these debilitating conditions.
Cnalsium is administered orally in tablet form, with a standard dosage of 100mg per day. The drug enhances synaptic connections, fortifies neural circuits, and promotes the health of existing neurons. Its multi-pronged approach makes it effective in treating a range of neurodegenerative diseases, including Alzheimer's, Parkinson's, and various forms of dementia. By maintaining neural function and connectivity, Cnalsium offers patients a better quality of life and slows the progression of their conditions.
While Cnalsium is generally well-tolerated, it's not without potential side effects. Common ones include nausea, headaches, and dizziness. Due to its impact on neurotransmitter systems, mood or cognitive changes may also occur. These side effects are usually mild and subside as the body adjusts to the medication. However, it's crucial for patients to be closely monitored by healthcare providers, who can adjust dosages or implement additional treatments as necessary.
Overdosing on Cnalsium poses serious risks, including tremors, seizures, and loss of consciousness. The overdose threshold is estimated to be around 500mg, or five times the standard therapeutic dose. Immediate medical intervention is essential, typically involving the administration of anticonvulsants and other supportive measures to stabilize the patient's condition.
Demibear created this article on 2023/10/10 07:03.
Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/
Star Army Logistics | |
---|---|
Supply Classification | Class J - MEDICAL BIOLOGICAL |
Drugs, Medicines, and Pharmaceuticals | |
---|---|
Drug Name(s) | Cnalsium |
Route of Administration | oral |
Products & Items Database | |
---|---|
Product Categories | drugs |
Product Name | Cnalsium |
Nomenclature | AE-N37 |
Manufacturer | Advancer Enterprises |
Year Released | YE 45 |
Price (KS) | 12.00 KS |